Glenmark Pharmaceuticals LtdPharmaceuticalsINE935A01035Consolidated₹2447.40+31.40 (+1.30%)Jun-26
Valuation
Market Cap₹69.07K Cr
TTM PE38.41x
Forward PE43.62x
PEG1.20
Book Value₹372.50
P/B6.57x
TTM EPS₹63.71
Fwd EPS₹56.11
TTM Revenue₹17.74K Cr
TTM PAT₹1.80K Cr
TTM EBITDA₹4.80K Cr
TTM EBIT₹4.18K Cr
Last Qtr PAT₹482.83 Cr
Last Qtr EBITDA₹804.79 Cr
Last Qtr EBIT₹631.62 Cr
Profitability
ROE17.10%
ROCE24.65%
TTM NPM10.14%
TTM EBITDA %27.04%
Curr OPM11.82%
Last OPM7.61%
Curr NPM—
Last NPM—
Curr EPS₹17.11
Last EPS₹10.68
Balance sheet
Equity₹28.22 Cr
Reserve₹10.48K Cr
Total Debt₹593.53 Cr
D/E0.06x
Interest %11.18%
Curr Interest₹54.00 Cr
Price / range
Close₹2447.40
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+1.30%
1W+1.17%
1M+6.18%
3M+13.62%
6M+11.93%
1Y+15.99%
2Y+48.77%
3Y+187.68%
5Y+371.70%
Diwali+20.84%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits